← All trials
NCT05681871
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 16, 2023
- Primary completion
- Aug 31, 2023
- Completion date
- Aug 31, 2023
- First posted
- Jan 12, 2023
- Last posted
- Jan 12, 2023
- Enrollment
- 420
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of Cape TownLead sponsor
- University of Cape TownReponsible party - principal investigator
- University of Kwa-Zulu NatalCollaborator
- Stellenbosch UniversityCollaborator
- University of Cape TownSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.